GH Alters Lymphatic Vessels in Female Mice and STAT5 Phosphorylation in Human Lymphatic Endothelial Cells
Endocrinology · 2026
DOI: 10.1210/endocr/bqaf194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2026. Verfasst von Christopher Walsh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA. Hauptthemen laut MEDLINE: Wound Healing, Growth Hormone, Lymphatic Vessels, STAT5 Transcription Factor. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Disruption of lymphatic function underlies a broad spectrum of inflammatory and metabolic disorders, yet the hormonal pathways that regulate lymphatic biology remain poorly defined. GH, which is implicated in similar disease states, has an unclear role in lymphatic homeostasis. To address this gap, we investigated how chronic alterations in GH signaling alter lymphatic structure and function. Using transgenic mouse lines with increased, decreased, or absent GH action, we quantified the effect of GH on lymphatic pumping rate and lymphangiogenic remodeling during wound healing using near-infrared fluorescent imaging. We also measured markers of lymphatic endothelial cells using Western blot and immunohistochemistry across multiple mouse organs. Lymphatic pumping rate positively correlated with GH action, whereas both elevated and absent GH signaling delayed wound healing. In contrast, the lymphatic vascular density and the expression of protein markers of lymphatic endothelial cells were inversely correlated with GH activity. Additionally, we showed that primary human dermal lymphatic endothelial cells express the GH receptor and exhibit acute GH-activated signaling and that this activation can be blocked with new and Food and Drug Administration-approved GH receptor antagonists. Together, these findings identify GH as a regulator of the lymphatic system and suggest that GH receptor antagonism could be a potential strategy to address lymphatic dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA.
- Institute for Molecular Medicine and Aging, Ohio University, Athens, OH 45701, USA.
- Department of Biological Sciences, Ohio University, Athens, OH 45701, USA.
- The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX 77030, USA.
- Early Drug Development, Infinix Bio LLC, Columbus, OH 43212, USA.
- Department of Medicine, Endocrinology, Erasmus Medical Center, 3015 GD, Rotterdam, The Netherlands.
ORCID-Profile: Reetobrata Basu, John J Kopchick
Zitieren
APA
Walsh, C., Scott, E., Wagner, E., Walsh, J., Reddy, S., Ahmad, A., Basu, R., Sevick-Muraca, E., Brody, R., Sandbhor, U., Neggers, S., & Kopchick, J. J. (2026). GH Alters Lymphatic Vessels in Female Mice and STAT5 Phosphorylation in Human Lymphatic Endothelial Cells. Endocrinology. https://doi.org/10.1210/endocr/bqaf194
Vancouver
Walsh C, Scott E, Wagner E, Walsh J, Reddy S, Ahmad A, et al. GH Alters Lymphatic Vessels in Female Mice and STAT5 Phosphorylation in Human Lymphatic Endothelial Cells. Endocrinology. 2026. doi:10.1210/endocr/bqaf194
BibTeX
@article{Walsh2026,
author = {Walsh, Christopher and Scott, Emily and Wagner, Elise and Walsh, Jerome and Reddy, Shashank and Ahmad, Arshad and Basu, Reetobrata and Sevick-Muraca, Eva and Brody, Rich and Sandbhor, Uday and Neggers, Sebastian and Kopchick, John J},
title = {GH Alters Lymphatic Vessels in Female Mice and STAT5 Phosphorylation in Human Lymphatic Endothelial Cells},
journal = {Endocrinology},
year = {2026},
doi = {10.1210/endocr/bqaf194}
}
EUVIMED